ENZO BIOCHEM INC Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Enzo Biochem Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Enzo Biochem Inc Share-based Payment Arrangement, Expense for the quarter ending April 30, 2024 was $207K, a 57.6% decline year-over-year.
  • Enzo Biochem Inc Share-based Payment Arrangement, Expense for the twelve months ending April 30, 2024 was $1.72M, a 10.5% increase year-over-year.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2023 was $2.27M, a 51.6% increase from 2022.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2022 was $1.5M, a 64.9% increase from 2021.
  • Enzo Biochem Inc annual Share-based Payment Arrangement, Expense for 2021 was $907K, a 2.79% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.27M +$772K +51.6% Aug 1, 2022 Jul 31, 2023 10-K 2023-11-03
2022 $1.5M +$589K +64.9% Aug 1, 2021 Jul 31, 2022 10-K 2023-11-03
2021 $907K -$26K -2.79% Aug 1, 2020 Jul 31, 2021 10-K 2022-10-14
2020 $933K -$6K -0.64% Aug 1, 2019 Jul 31, 2020 10-K 2022-10-14
2019 $939K Aug 1, 2018 Jul 31, 2019 10-K 2021-10-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.